Type 1 Diabetes


The goal of our program is to improve the lives of all people living with type 1 diabetes (T1D). Working closely with key players across the T1D ecosystem – patients, physicians, caregivers, researchers, government agencies, funders, pharmaceutical companies, device makers, insurers, and community organizations – we seek to improve care and ultimately prevent the disease. 


Improve Outcomes for People With T1D

In the U.S., over 1.5 million people live with T1D and approximately 30,000 are diagnosed every year. We seek to help provide the best possible resources for all people with T1D and their caregivers to ease the burden of managing this relentless disease, improve quality of life, and extend life spans.

Learn more about our four key priorities.

Prevent and Delay the Disease

T1D develops due to a combination of genetic and environmental factors. However, the exact causes of the disease remain unknown and there are no viable methods of prevention. We strive to build the blocks to understand, eradicate, and treat T1D.

Learn more about our three key priorities. 

Funding Opportunities

Currently, there are no open Helmsley T1D funding opportunities.